NARCAN TWINDOSE

Serial Number 98202343
732

Registration Progress

Application Filed
Sep 28, 2023
Under Examination
Jul 2, 2024
Approved for Publication
May 7, 2024
Published for Opposition
May 7, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 02, 2026 153 days

Trademark Image

NARCAN TWINDOSE

Basic Information

Serial Number
98202343
Filing Date
September 28, 2023
Published for Opposition
May 7, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Dec 17, 2025
Application
Pending
Classes
005

Rights Holder

Emergent Operations Ireland Limited

99
Address
6 Earlsfort Terrace, 6th Floor
Dublin 2
IE

Ownership History

Emergent Operations Ireland Limited

Original Applicant
99
Dublin IE

Emergent Operations Ireland Limited

Owner at Publication
99
Dublin IE

Legal Representation

Attorney
Virginia Wolk Marino

USPTO Deadlines

Next Deadline
153 days remaining
NOA E-Mailed - SOU Required
Due Date
July 02, 2026
Extension Available
Until January 02, 2027

Application History

28 events
Date Code Type Description Documents
Dec 18, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 17, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 17, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 17, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 28, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 27, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 27, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 2, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 2, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 2, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 2, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 1, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 1, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 1, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 1, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 1, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 13, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 12, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 2, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; Auto-injectors, syringes, intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations; pharmaceutical and drug preparations for use in treatment of substance overdose

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TWINDOSE"